Cohance Lifesciences Limited has informed the Exchange about disclosure under SEBI PIT Regulations
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences Limited has submitted a disclosure to the stock exchange under SEBI's Prohibition of Insider Trading (PIT) Regulations. This typically relates to the buying or selling of company shares by designated insiders such as promoters, directors, key managerial personnel, or their relatives. The announcement does not mention any violation, penalty, or investigation — it appears to be a routine compliance filing as required under PIT norms.
This is a routine regulatory disclosure and is unlikely to have any material impact on the stock price. Investors may want to check the details of the insider trade for context, but no negative signal is implied.